Abstract
The efficacy of the application of botulinum toxin type A (BTX-A) and hyaluronic acid (HA) as minimally invasive treatments in facial rejuvenation has been previously demonstrated. The local side effects most frequently observed are pain, swelling, erythema, and bruising. In spite of the limited and benign nature of these events, they usually cause discomfort for the patient who is looking for aesthetic improvement.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
